Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Cancer Immunotherapy Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Cancer Immunotherapy Market, by Type, 2020-2028 (USD Billion)
1.2.3. Global Cancer Immunotherapy Market, by Application, 2020-2028 (USD Billion)
1.2.4. Global Cancer Immunotherapy Market, by End User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Immunotherapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Immunotherapy Market Dynamics
3.1. Cancer Immunotherapy Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing incidence of cancer worldwide
3.1.1.2. Rising adoption of immunotherapy over other treatment options
3.1.2. Market Challenges
3.1.2.1. Availability of limited funds to initiate clinical trials
3.1.2.2. High cost of treatment
3.1.3. Market Opportunities
3.1.3.1. Increasing clinical trials for the treatment of cancers
3.1.3.2. High growth prospects in emerging nations
Chapter 4. Global Cancer Immunotherapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cancer Immunotherapy Market, by Type
6.1. Market Snapshot
6.2. Global Cancer Immunotherapy Market by Type, Performance - Potential Analysis
6.3. Global Cancer Immunotherapy Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
6.4. Cancer Immunotherapy Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Cancer Vaccines
6.4.3. Checkpoint Inhibitors
6.4.4. Immunomodulators
Chapter 7. Global Cancer Immunotherapy Market, by Application
7.1. Market Snapshot
7.2. Global Cancer Immunotherapy Market by Application, Performance - Potential Analysis
7.3. Global Cancer Immunotherapy Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
7.4. Cancer Immunotherapy Market, Sub Segment Analysis
7.4.1. Lung Cancer
7.4.2. Breast Cancer
7.4.3. Head and Neck Cancer
7.4.4. Prostate Cancer
7.4.5. Colorectal Cancer
7.4.6. Melanoma
7.4.7. Others
Chapter 8. Global Cancer Immunotherapy Market, by End User
8.1. Market Snapshot
8.2. Global Cancer Immunotherapy Market by End User, Performance - Potential Analysis
8.3. Global Cancer Immunotherapy Market Estimates & Forecasts by End User 2018-2028 (USD Billion)
8.4. Cancer Immunotherapy Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Clinics & Others
Chapter 9. Global Cancer Immunotherapy Market, Regional Analysis
9.1. Cancer Immunotherapy Market, Regional Market Snapshot
9.2. North America Cancer Immunotherapy Market
9.2.1. U.S. Cancer Immunotherapy Market
9.2.1.1. Type estimates & forecasts, 2018-2028
9.2.1.2. Application estimates & forecasts, 2018-2028
9.2.1.3. End User estimates & forecasts, 2018-2028
9.2.2. Canada Cancer Immunotherapy Market
9.3. Europe Cancer Immunotherapy Market Snapshot
9.3.1. U.K. Cancer Immunotherapy Market
9.3.2. Germany Cancer Immunotherapy Market
9.3.3. France Cancer Immunotherapy Market
9.3.4. Spain Cancer Immunotherapy Market
9.3.5. Italy Cancer Immunotherapy Market
9.3.6. Rest of Europe Cancer Immunotherapy Market
9.4. Asia-Pacific Cancer Immunotherapy Market Snapshot
9.4.1. China Cancer Immunotherapy Market
9.4.2. India Cancer Immunotherapy Market
9.4.3. Japan Cancer Immunotherapy Market
9.4.4. Australia Cancer Immunotherapy Market
9.4.5. South Korea Cancer Immunotherapy Market
9.4.6. Rest of Asia Pacific Cancer Immunotherapy Market
9.5. Latin America Cancer Immunotherapy Market Snapshot
9.5.1. Brazil Cancer Immunotherapy Market
9.5.2. Mexico Cancer Immunotherapy Market
9.6. Rest of The World Cancer Immunotherapy Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Amgen, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Astrazeneca, PLC
10.2.3. F. Hoffmann-La Roche, Ltd. (Genentech, Inc.)
10.2.4. Bayer AG
10.2.5. Eli Lily And Company
10.2.6. Novartis AG
10.2.7. Pfizer, Inc.
10.2.8. Johnson & Johnson (Janssen Global Services, LLC)
10.2.9. Bristol-Myers Squibb Company
10.2.10. Merck KGAA
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption